Since getting FDA approval, Azilect has seen its cost jump more than 200 percent over the past decade
From: http://redirect.viglink.com?u=http%3A%2F%2Fwww.cbsnews.com%2Fnews%2Ftevas-pricey-parkinsons-drug-azilect-unnerves-some-patients%2F&key=ddaed8f51db7bb1330a6f6de768a69b8
No comments:
Post a Comment